FTC settlement frameworks for major PBMs mandate transparency to plan sponsors, fee-based remuneration, limits on spread ...

Multidisciplinary care is a cornerstone of modern management for high- and very-high-risk cutaneous squamous cell carcinoma ...

Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...

Beyond standard risk scores, the guideline highlights key risk enhancers—including lipoprotein(a), inflammation markers, and ...

The VESALIUS-CV trial, published in JAMA and presented at ACC 2026 as a late-breaking abstract, marks a significant expansion ...

As long-acting HIV therapies move into broader clinical use, real-world data are shedding light on an important practical ...

The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...

Actigraphy showed weeknight sleep increased by 47 minutes, raising mean duration from 6.48 to 7.27 hours; weekend sleep ...

COA's annual conference hits Orlando April 28, focusing on AI, targeted therapy innovation, and state-level oncology advocacy ...

Christine Pfaff, RPh, MBA, director of clinical initiatives at the Community Oncology Alliance (COA), sees this year’s ...

Global MASH cirrhosis burden is rapidly increasing, yet therapeutic and prognostic frameworks remain limited, with sparse ...

Community oncology practices are on the front lines of cancer care innovation, yet they face mounting external pressures that ...